The Asia Pacific\u00a0PV\u00a0device market will\u00a0grow modestly\u00a0over the forecast period, driven by the high prevalence of\u00a0PAD, an expanding patient population, and rising adoption of premium-priced drug-eluting products.\u00a0Rising\u00a0procedure volumes for iliac and lower limb indications and the increasing adoption of endovascular techniques over surgical intervention will also fuel market\u00a0growth. However, cost constraints in publicly funded healthcare systems and limited reimbursement in the region continue to hinder adoption of premium-priced devices and limit the pace of revenue expansion.<\/p>\n
This Medtech 360 Report provides high-level market metrics for\u00a0PV\u00a0devices in Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific\u00a0from 2019 through 2032.<\/p>\n","protected":false},"template":"","class_list":["post-385673","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-peripheral-vascular-devices","medtech-geography-asia-pacific","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385673\/revisions"}],"predecessor-version":[{"id":387192,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385673\/revisions\/387192"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}